Back to speakers

Nezam AFDHAL

Chief of Hepatology, Beth Israel Deaconess Medical Center, Professor of Medicine, Harvard Medical School

USA

City: Boston

Institution: Harvard Medical School / Beth Israel Deaconess Medical Center

Contact: nafdhal@bidmc.harvard.edu


Biography of Nezam AFDHAL

Nezam H. Afdhal, MD, is Chief of Hepatology and director of the Liver Center at Beth Israel Deaconess Medical Center in Boston, Massachusetts. He is also Professor of Medicine at Harvard Medical School. Dr. Afdhal received his MD degree in 1981 from the Royal College of Surgeons in Ireland and did fellowship training at University College Dublin and at Boston University School of Medicine.

 

Dr. Afdhal’s clinical expertise focuses on the management of the complications of liver disease, including cirrhosis and portal hypertension. He is the director of a clinical trials group focusing on novel treatments of hepatitis B and C, liver fibrosis and NASH. Additional research interests include basic and translational research in gallstone disease, liver cancer and in liver fibrosis. His research is funded by multiple NIH, industry and foundation grants.

 

Dr. Afdhal has served on multiple State and National advisory boards for liver disease. He has served as on the Editorial Board and as a reviewer for multiple journals. He has published more than 200 papers in journals such as New England Journal of Medicine, Gastroenterology, Hepatology, Gut, and Journal of Hepatology, as well as 30 book chapters and 2 books. He is the Editor for the Journal of Viral Hepatitis. He has spoken nationally and internationally on chronic liver disease and received many awards, including the American Liver Foundation Award for Excellence, a Fullbright Scholarship and the Mitchell Lectureship of the Royal College of Physicians. He is a member of the American Gastroenterological Association, the American Association for the Study of Liver Diseases, and the European Association for the Study of the Liver.

PHC's participations

10th PHC – 2017

Monday, January 30th 2017

HEPATITIS C - SESSION 2 (chairman)

LUNCH WORKSHOPS - 1-Future therapies for HBV and HDV: What can we expect? (chairman)

9th PHC – 2016

Monday, January 11th 2016

How to improve access to therapy? Around the World table - NORTH & WEST (chairman) -

8th PHC – 2015

Monday, January 12th 2015

How to optimize current therapy of G1 patients (chairman)

Tuesday, January 13th 2015

Lunch Workshops - Room 241 (chairman) -

6th PHC – 2013

Monday, January 14th 2013

How to optimize current therapy of G1 patients (chairman)

Tuesday, January 15th 2013

Interactive Luncheons - Room 6 (chairman)

5th PHC – 2012

Monday, January 30th 2012

Interactive luncheons - Room 4 (chairman)

Tuesday, January 31st 2012

Controversies Part 1 (chairman)

4th PHC – 2011

Monday, January 17th 2011

Hepatitis C: towards a personalised management (chairman)

Interactive luncheons - Room 1 (chairman)

3rd PHC – 2009

Monday, January 19th 2009

(chairman)

2nd PHC – 2007

Monday, January 22nd 2007

4th session (chairman)

Clinical case -

10th PHC – 2017

Monday, January 30th 2017

HEPATITIS C - SESSION 2 (chairman)

LUNCH WORKSHOPS - 1-Future therapies for HBV and HDV: What can we expect? (chairman) -